Delorean Corporation has banked a $5.76 million cash refund from the Australian Government’s FY2025 R&D Tax Incentive, underpinning its bioenergy infrastructure growth. Another refund linked to FY2026 expenditure is anticipated next year.
- Received $5.76 million R&D tax refund for FY2025
- Further refund expected from FY2026 eligible expenditure
- Supports bioenergy and waste management projects
- Vertically integrated operations across engineering, infrastructure, retail
- Refund enhances cash flow amid active project development
Cash Injection from R&D Tax Incentive
Delorean Corporation (ASX:DEL) has received a significant $5.76 million cash refund under the Australian Federal Government’s FY2025 Research and Development Tax Incentive program. This refund rewards the company’s eligible R&D expenditure during the financial year and provides a welcome boost to its cash position as it advances its bioenergy infrastructure projects.
The company also flagged a further cash refund expected in the next financial year, related to its ongoing FY2026 R&D activities. While the exact amount remains undisclosed, this suggests a continued commitment to innovation within its renewable energy and waste management operations.
Bioenergy Focus and Vertical Integration
Delorean’s business model integrates engineering, infrastructure development, and energy retailing, enabling it to oversee bioenergy projects from conception through to operation. By processing organic waste and generating renewable energy, Delorean not only contributes to reducing landfill volumes but also creates multiple revenue streams, including green electricity, heat, and gas sales.
This R&D refund arrives as Delorean is actively progressing major bioenergy projects, including the SA1 Salisbury and NSW1 Horsley Park facilities. These developments have been supported by recent capital initiatives such as the $2.2 million Share Purchase Plan designed to fund construction phases, highlighting a period of intensified investment and expansion.
Strategic Timing Amid Project Milestones
The timing of the refund complements Delorean’s recent positive Final Investment Decision for the NSW1 Horsley Park bioenergy facility, backed by $30.5 million in government grants. This project, along with ongoing construction at SA1 Salisbury, positions Delorean to scale its renewable energy output significantly in the near term.
Such government incentives, both through grants and R&D tax refunds, play a critical role in underpinning Delorean’s capital-intensive bioenergy infrastructure. The cash inflow from the R&D program not only offsets project costs but also supports the company’s transition towards a build-own-operate model, which has seen growing pains but also promising milestones in recent quarters.
Bottom Line?
Delorean’s R&D tax refund strengthens its financial footing as it pushes ahead with bioenergy projects, but the scale of future refunds and their impact on profitability remain to be seen.
Questions in the middle?
- How will the expected FY2026 R&D refund influence Delorean’s cash flow and project funding?
- What proportion of Delorean’s R&D expenditure directly supports its flagship bioenergy facilities?
- Can ongoing government incentives sustain Delorean’s transition to a build-own-operate bioenergy model?